LATEST
WEBSTORY
TRENDING

This company of Mukesh Ambani made sales worth Rs 4000000000 in a year by selling...

Article 370 OTT release: Here's when and where you can enjoy Yami Gautam's political thriller

Remember Sana Saeed? SRK's daughter in Kuch Kuch Hota Hai, here's how she looks after 26 years, she's dating..

5 films Jackie Shroff rejected, including two blockbusters

7 superfoods to consume instead of multivitamins

World's most expensive fish costs Rs....

BJP appoints new state presidents in Telangana, Jharkhand, Punjab, Andhra ahead of 2024 Lok Sabha polls

Meet 'mystery girl' whose pictures with Indian cricketer Yuzvendar Chahal is going viral

SCO must not hesitate to criticise countries supporting terrorism: PM Modi

PHOTOS
VIDEOS
ENTERTAINMENT

Remember Sana Saeed? SRK's daughter in Kuch Kuch Hota Hai, here's how she looks after 26 years, she's dating..

In pics: Rajinikanth, Kamal Haasan, Mani Ratnam, Suriya attend S Shankar's daughter Aishwarya's star-studded wedding

In pics: Sanya Malhotra attends opening of school for neurodivergent individuals to mark World Autism Month

Lawrence Bishnoi’s Brother Anmol Takes Responsibility Of Firing Outside Salman Khan’s Home

Manipur: Fresh Violence Erupts In Manipur, 2 Killed Ahead Of Home Minister Amit Shah's Visit

Israel-Iran Row: Iran Fired 300 Missiles, Drones Overnight, Israel Calls For Emergency UNSC Meet

Article 370 OTT release: Here's when and where you can enjoy Yami Gautam's political thriller

Remember Sana Saeed? SRK's daughter in Kuch Kuch Hota Hai, here's how she looks after 26 years, she's dating..

This flop film with two stars pushed director into debt, protestors tore his clothes, vandalised his office, then he...

Home Business

Business

Cipla only Indian company contending for Kremers Urban

Previously , Lupin Pharmaceuticals and Torrent Pharma were in the race but later dropped out.

DNA Web Team

Updated : Mar 20, 2018, 04:17 AM IST

Representational image

Pharmaceutical company Cipla is the only Indian company in the bidding for Kremers Urban, a specialty generics drug business, an ET report has said. A deal that is likely to cost $1.3 billion, had previously seen interest from Lupin Pharmaceuticals and Torrent Pharma, but they later dropped out of the race.

However, Cipla faces tough competition with prominent private equity players, which includes China's China Grand Group.

UCB, Kremers Urban's parent company, had in 2014 put the company for sale in a bid to reduce its own debt and to focus on its more core businesses -- immunology and neurological medicines.

Kremers reported sales worth $463 million in 2014.

Cipla reported an over two-fold jump in consolidated net profit of rs 650.61 crore for the quarter ended June 30, 2015, mainly on account of robust sales. The company had posted a net profit of Rs 294.58 crore for the corresponding period of the previous fiscal, Cipla had said in a statement.

Find your daily dose of news & explainers in your WhatsApp. Stay updated, Stay informed- Follow DNA on WhatsApp.